Tarsus Pharmaceuticals, Inc. ($TARS)
Filing Information
| Accession Number | 0001827672-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 9, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
157,499
Total Value
$0.00
P&L
+inf% (+$10,160,260.49)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Stock Option (right to buy) | Derivative | Mar 5, 2026 | Grant/Award | 96,723 | $0.00 | $0.00 | 96,723 | Direct | โ | View Details | |
Director | Restricted Stock Units | Derivative | Mar 5, 2026 | Grant/Award | 60,776 | $0.00 | $0.00 | 60,776 | Direct | โ | View Details |